ACQUISITION OF FEMTOLASERS (Details) (FEMTOLASERS)	0 Months Ended		3 Months Ended
	Feb. 11, 2015 USD ($)	Feb. 11, 2015 EUR (€)	Apr. 04, 2015 USD ($)	Mar. 29, 2014 USD ($)	Feb. 11, 2015 USD ($)	Feb. 11, 2015 EUR (€)	Feb. 11, 2015 Developed technology USD ($)	Feb. 11, 2015 In-process research and development USD ($)	Feb. 11, 2015 Other intangible assets USD ($)	Feb. 11, 2015 Selling, general and administrative expenses USD ($)
ACQUISITIONS AND FEMTOLASERS
Initial purchase price		€ 9,100,000
Reduction in purchase price due to net asset adjustment		1,600,000
Adjusted purchase price	8,500,000	7,500,000
Purchase price deposited at closing into escrow account						2,300,000
Time period for depositing into escrow from the date of closing	30 months	30 months
Transaction costs incurred										400,000
Repayment of outstanding loan	4,000,000	3,600,000
Purchase price, assets acquired and liabilities assumed
Cash					78,000
Accounts receivable					2,007,000
Inventories					2,315,000
Deferred tax assets					596,000
Other assets					2,057,000
Goodwill					7,841,000
Intangible assets							1,811,000	1,664,000	543,000
Accounts payable					(3,417,000)
Debt					(4,021,000)
Deferred tax liabilities					(1,005,000)
Other liabilities					(1,974,000)
Assets acquired and liabilities assumed, total					8,495,000
Supplemental pro forma financial information, Actual
Net sales			350,000
Net loss attributable to Newport Corporation			(460,000)
Supplemental pro forma information:
Net sales			156,924,000	149,328,000
Net income attributable to Newport Corporation			8,999,000	7,758,000
Pro forma increase (decrease) in amortization expense			100,000	100,000
Transaction costs excluded from pro forma net income			$ 400,000	$ 400,000